SENSICARDIAC vs Imbio PHA (4.0.0)
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
AI Verdict
SENSICARDIAC focuses on AI-powered heart murmur detection using electronic stethoscopes for initial screening and diagnosis. In contrast, Imbio PHA (4.0.0) specializes in automated cardiac structure measurements from CT pulmonary angiogram scans to assess conditions like pulmonary embolism and hypertension. While both are cardiology AI tools, their distinct input data (audio vs. imaging) and specific diagnostic applications mean they address different clinical needs rather than directly competing.
Choose SENSICARDIAC if…
Choose SENSICARDIAC if you are a clinician seeking an AI-powered solution for real-time heart murmur detection and classification using electronic stethoscopes. This tool is ideal for primary care physicians or telehealth providers who need to quickly screen patients for potential cardiac issues, reduce unnecessary specialist referrals, and provide remote cardiac care with live diagnostic quality stethoscope streaming.
View SENSICARDIAC →Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if your practice requires automated, AI-driven analysis of CT pulmonary angiogram (CTPA) scans to precisely measure cardiac structures. This software is best suited for radiologists and cardiologists focused on diagnosing and risk stratifying pulmonary embolism and hypertension, providing rapid, quantitative insights into right ventricular dilation directly from imaging data.
View Imbio PHA (4.0.0) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | SENSICARDIAC | Imbio PHA (4.0.0) |
|---|---|---|
| Deployment | SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser. | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | SENSICARDIAC | Imbio PHA (4.0.0) |
|---|---|---|
| Tool Name | SENSICARDIAC | Imbio PHA (4.0.0) |
| Company | DIACOUSTIC MEDICAL (PTY) | Imbio |
| Primary Function | AI-powered, cloud-based heart murmur detection service that integrates with electronic stethoscopes to classify murmurs as pathological or physiological, aiding physicians in diagnosis and reducing unnecessary referrals. | FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. |
| Input Data Type | Electronic stethoscope data | CT pulmonary angiogram (CTPA) scans |
| Key AI-Powered Analysis | Heart murmur classification (Class I: dangerous pathological, Class III: innocent physiological) against a large validated database. | Automated measurement of right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculation of RV/LV and PA/Ao ratios. |
| Output Format | Detailed cardiac reports (downloadable PDFs, visualization, S1/S2 indicators) | Annotated DICOM images, summary reports in PDF format |
Videos
Demos, reviews, and walkthroughs featuring SENSICARDIAC and Imbio PHA (4.0.0).
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
SENSICARDIAC is designed for real-time auscultation, aiding physicians in the immediate classification of heart murmurs as pathological or physiological and guiding referral decisions. Imbio PHA, conversely, processes CT pulmonary angiogram (CTPA) scans post-acquisition to provide automated cardiac structure measurements for diagnosing and risk stratifying pulmonary embolism and hypertension.
SENSICARDIAC provides downloadable PDF cardiac reports and visualizations, which can be integrated into EHRs. Imbio PHA generates annotated DICOM images and PDF summary reports, integrating directly with native DICOM tools and workflows for seamless incorporation into imaging archives and patient records.
SENSICARDIAC performs analysis against a large validated database of pathological heart murmurs to classify them as dangerous pathological (Class I) or innocent physiological (Class III). Imbio PHA utilizes artificial intelligence algorithms for automated anatomical identification and precise measurement of cardiac structures from CTPA scans, with clinical performance validation showing accuracy in measuring RV/LV and PA/Ao ratios compared to expert radiologists.
SENSICARDIAC features a guided auscultation process and real-time analysis, suggesting a relatively quick adoption for immediate diagnostic support. Imbio PHA offers rapid, fully-automated assessment typically in minutes, implying a fast turnaround for image analysis once integrated into existing DICOM workflows.
SENSICARDIAC, being cloud-based and integrating with electronic stethoscopes, would require managing device distribution and ensuring consistent cloud access across sites. Imbio PHA offers deployment flexibility with cloud, enterprise (on-premise), or partner options, which can be tailored to multi-site IT infrastructure and security policies.
SENSICARDIAC generates detailed cardiac reports in PDF format, providing a record of each analysis performed. Imbio PHA produces annotated DICOM images and PDF summary reports, which can be tracked within existing PACS and imaging workflows, offering a robust audit trail for image-based assessments.